Related references
Note: Only part of the references are listed.Perception of side effects associated with anticancer treatment in women with breast or ovarian cancer (KEM-GO-1): a prospective trial
Beyhan Ataseven et al.
SUPPORTIVE CARE IN CANCER (2020)
A new class of 1,3,5-triazine-based selective estrogen receptor degraders (SERDs): Lead optimization, molecular docking and dynamic simulation
Xiang Lu et al.
BIOORGANIC CHEMISTRY (2020)
Recent progress in small molecule agents for the targeted therapy of triple-negative breast cancer
Rajibul Islam et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Antiproliferative effect of mitochondria-targeting allobetulin 1,2,3-triazolium salt derivatives and their mechanism of inducing apoptosis of cancer cells
Rui Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer
Gang Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
Wei Cao et al.
BREAST CANCER RESEARCH (2019)
Diosgenin inhibited the expression of TAZ in hepatocellular carcinoma
Zhize Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Rottlerin upregulates DDX3 expression in hepatocellular carcinoma
Zhong Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Discovery of novel mifepristone derivatives via suppressing KLF5 expression for the treatment of triple-negative breast cancer
Yuqi Lin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies
Heba E. Elsayed et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer
Rashmi Verma et al.
BREAST CANCER RESEARCH (2016)
Effect of Hecogenin on DNA instability
Marina Sampaio Cruz et al.
TOXICOLOGY REPORTS (2016)
Modes of cancer cell invasion and the role of the microenvironment
Andrew G. Clark et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
Hecogenin Acetate Inhibits Reactive Oxygen Species Production and Induces Cell Cycle Arrest and Senescence in the A549 Human Lung Cancer Cell Line
Juciano Gasparotto et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2014)
Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells
Jian Kang et al.
BMC CANCER (2014)
Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships
Maciej Serda et al.
PLOS ONE (2014)
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
Brian D. Lehmann et al.
BREAST CANCER RESEARCH (2014)
Chemical characterization, antioxidant and antibacterial activities of six Agave species from Sinaloa, Mexico
Yesmi Patricia Ahumada-Santos et al.
INDUSTRIAL CROPS AND PRODUCTS (2013)
Evidence for the Involvement of Descending Pain-Inhibitory Mechanisms in the Antinociceptive Effect of Hecogenin Acetate
Kelly Barbosa Gama et al.
JOURNAL OF NATURAL PRODUCTS (2013)
Synthesis and characterization of quinoline-based thiosemicarbazones and correlation of cellular iron-binding efficacy to anti-tumor efficacy
Maciej Serda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice
Gilberto Santos Cerqueira et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
MONITAING OF THE PATENT TECHNOLOGIES OF HECOGENIN
Mairim Russo Serafini et al.
REVISTA GEINTEC-GESTAO INOVACAO E TECNOLOGIAS (2012)
Novel Thiosemicarbazones of the ApT and DpT Series and Their Copper Complexes: Identification of Pronounced Redox Activity and Characterization of Their Antitumor Activity
Patric J. Jansson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Design, synthesis, and antimalarial activity of structural chimeras of thiosemicarbazone and ferroquine analogues
Christophe Biot et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment
J Yuan et al.
BLOOD (2004)
Share Paper
